| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R” |
| 06/13/2006 | US7060828 Angiogenosis inhibitor; anticancer agents |
| 06/08/2006 | WO2006059400A1 Antibiotics fki-2140, method of producing the same and strain producing the same |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122388 Thiocarbamate inhibitors of alpha-4 integrins |
| 06/08/2006 | US20060122252 Novel antituberculosis compounds, Hirsutellones A, B, and C |
| 06/08/2006 | US20060122251 and elevated intraocular pressure; e.g. 2-(7,8-Dihydro-[1,4]dioxino[2,3-g]indazol-1-yl)-1-methyl-ethylamine; serotonin 5-HT2 receptor agonists; chemical stability, sustained release |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122199 anti-invasive agent for use in the containment and/or treatment of solid tumour disease; little activity against VEGF receptor tyrosine kinase; synergistic use with other anticancer agents; 4-(5-chloro-2,3-methylenedioxypyrid-4-ylamino)-6-methoxy-7-[3-(4-prop-2-ynylpiperazin-1-yl)propoxy]quinazoline |
| 06/08/2006 | US20060122178 Compounds having activity as inhibitors of apoptosis |
| 06/08/2006 | US20060122167 C6-and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666468A1 Crf antagonists and heterobicyclic compounds |
| 06/07/2006 | EP1664054A1 Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin |
| 06/07/2006 | EP1664043A2 Compositions useful as inhibitors of protein kinases |
| 06/07/2006 | EP1664038A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved i in vivo /i efficacy |
| 06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 06/07/2006 | EP1663999A2 Inhibitors of phosphodiesterase type-iv |
| 06/07/2006 | EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 06/07/2006 | EP1663107A2 Rifamycin analogs and uses thereof |
| 06/07/2006 | EP1599469B1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/07/2006 | EP1315732B1 Radicicol and monocillin and their analogues and uses thereof |
| 06/07/2006 | EP1147113B1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1781923A Method for preparing 9-nitro-20(s)-camptothecine |
| 06/07/2006 | CN1781922A Camptothecine derivative, preparing method and use |
| 06/07/2006 | CN1781921A Compounds for treating impaired fundic relaxation |
| 06/06/2006 | US7057048 Androgen receptor antagonists |
| 06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/06/2006 | US7057044 Aporphine and oxoaporphine compounds and pharmaceutical use thereof |
| 06/06/2006 | US7057042 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 06/06/2006 | US7056929 Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/06/2006 | CA2145514C Process for the preparation of 9-amino camptothecin |
| 06/01/2006 | WO2006056850A2 Chroman compounds |
| 06/01/2006 | WO2006056282A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
| 06/01/2006 | WO2006056281A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116415 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116378 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 06/01/2006 | US20060116363 Tricyclic derivatives as ltd4 antagonists |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | DE102004056820A1 Preparation of dihydroindene derivatives comprises reacting benzene compounds with indene compounds in the presence of catalyst system containing e.g. ligand and a solvent system containing two solvents from e.g. tertiary amine and alcohol |
| 06/01/2006 | CA2595602A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
| 06/01/2006 | CA2587860A1 Chroman compounds |
| 06/01/2006 | CA2586096A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 05/31/2006 | EP1660088A2 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1270579B1 Process for producing camptothecin |
| 05/31/2006 | CN1780835A Novel fused heterocycles and uses thereof. |
| 05/31/2006 | CN1780834A Imidazopyridine intermediates |
| 05/31/2006 | CN1780831A 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 05/31/2006 | CN1780625A Isoquinoline derivatives and methods of use thereof |
| 05/31/2006 | CN1780624A Tetracyclic benzamide derivatives and methods of use thereof |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053210 Efficient synthesis of pyropheophorbide a and its derivatives |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053112 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053102 A beta -hydroxylactone replaces the natural alpha -hydroxylactone of camptothecin; for treating colon and breast cancer |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
| 05/26/2006 | WO2006054912A1 Aryl(hetaryl)-3-aminomethyl-quinilone-2 derivatives in the form of no-synthetase i and cyclooxygenase-2 nhibitors, methods for the production thereof and compositions based thereon |
| 05/26/2006 | WO2006054494A1 PROCESS FOR PRODUCING BENZO[c]PHENANTHRIDINE DERIVATIVE |
| 05/26/2006 | CA2584617A1 Process for producing benzo[c]phenanthridine derivative |
| 05/25/2006 | US20060111380 4-(2-naphtyl)-2-[3-oxospiro[isobenzofuran-1 (3H), 4'-piperidin]-1'-yl]-1H-imidazole, 4-(4-bromophenyl)-2-[3-oxospiro[isobenzofuran-1(3H),4'-piperidin]-1-yl]-1H imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 05/25/2006 | US20060111341 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 05/25/2006 | US20060107869 Inks for digital textile printing with reactive yellow fluorescent dyes |
| 05/24/2006 | EP1658495A1 Novel chemiluminescent compounds and their use |
| 05/24/2006 | EP1658282A1 Novel chelating agents and chelates and their use |
| 05/24/2006 | CN1777611A Novel process for the preparation of hexacyclic camptothecin |
| 05/24/2006 | CN1777604A Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives |
| 05/24/2006 | CN1777590A Indazole derivatives |
| 05/23/2006 | US7049437 Particularly a crystal of 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo(4,5-d) pyrano(4,3-b)pyridine phosphate monohydrate |
| 05/23/2006 | US7049327 For therapy of pain |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049315 Solubilized topoisomerase poisons |
| 05/23/2006 | US7049310 Therapy for bacteria infections |